G. Charles Robb
2018
In 2018, G. Charles Robb earned a total compensation of $2.8M as Chief Financial Officer and Secretary at Corcept Therapeutics, a 60% increase compared to previous year.
Compensation breakdown
| Bonus | $237,600 |
|---|---|
| Option Awards | $2,171,400 |
| Salary | $436,667 |
| Total | $2,845,667 |
Robb received $2.2M in option awards, accounting for 76% of the total pay in 2018.
Robb also received $237.6K in bonus and $436.7K in salary.
Rankings
In 2018, G. Charles Robb's compensation ranked 4,090th out of 14,244 executives tracked by ExecPay. In other words, Robb earned more than 71.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,090 out of 14,244 | 71st |
Division Manufacturing | 1,506 out of 5,759 | 74th |
Major group Chemicals And Allied Products | 536 out of 2,122 | 75th |
Industry group Drugs | 448 out of 1,811 | 75th |
Industry Pharmaceutical Preparations | 345 out of 1,385 | 75th |
Source: SEC filing on April 24, 2019.
Robb's colleagues
We found four more compensation records of executives who worked with G. Charles Robb at Corcept Therapeutics in 2018.